Trial intelligence / Profile preview

FOCUS: Pharmacokinetics of fluconazole in children and adolescents

2024-518305-17-01Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Dec 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of fluconazole in invasive mycoses, sponsored by Radboud University Medical Center. Primary endpoint: Population pharmacokinetic parameters of fluconazole. Started Dec 2024; status: completed.

02

Drugs

fluconazole
03

Conditions

invasive mycoses

Beyond the preview

Go deeper on 2024-518305-17-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-518305-17-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call